Hemp vs Marathon Which Is a Smarter Choice?
Hemp and Marathon stocks are two distinct investment opportunities that appeal to different types of investors. Hemp stocks are related to the rapidly growing hemp industry, which includes products such as CBD oil and industrial hemp used for textiles and construction materials. On the other hand, Marathon stocks are related to the energy sector, specifically companies involved in oil refining and marketing. Each type of stock presents unique opportunities and risks for investors looking to diversify their portfolios.
Hemp or Marathon?
When comparing Hemp and Marathon, different investors may prioritize various metrics based on their investment strategies and goals. So, ask yourself what type of investor you are. This will guide you in determining which metrics are most important for your investment decision between Hemp and Marathon.
Dividend Investors:
Dividend investors look for stable and growing income streams, using dividend metrics to assess potential investments. A company's dividend yield essentially measures the size of its dividend relative to the total market value of the company.
Hemp has a dividend yield of -%, while Marathon has a dividend yield of -%. Beyond the yield itself, considering the growth and sustainability of these dividends is also crucial. Hemp reports a 5-year dividend growth of 0.00% year and a payout ratio of 0.00%. On the other hand, Marathon reports a 5-year dividend growth of 0.00% year and a payout ratio of 0.00%.
Value Investors:
Value investors focus on financial metrics to determine a stock's intrinsic value compared to its market value. The Price-to-Earnings (P/E) Ratio links stock price to a company's earnings per share, with Hemp P/E ratio at 0.00 and Marathon's P/E ratio at 0.00. Another crucial valuation metric is the Price-to-Book (P/B) Ratio, which compares stock price with book value per share. Hemp P/B ratio is 0.00 while Marathon's P/B ratio is 0.00.
Growth Investors:
Growth investors prioritize metrics indicative of a company's expansion potential. Focusing on top-line growth, Hemp has seen a 5-year revenue growth of 0.00%, while Marathon's is 0.00%. Return on Equity (ROE) measures how effectively a company uses equity investment to generate earnings, with Hemp's ROE at 0.00% and Marathon's ROE at 0.00%.
Retail Investors:
Retail investors often consider stock affordability and company familiarity. For example, day low prices are $0.00 for Hemp and $0.00 for Marathon. Over the past year, Hemp's prices ranged from $0.00 to $0.00, with a yearly change of 1900.00%. Marathon's prices fluctuated between $0.00 and $0.00, with a yearly change of 9900.00%. Brand recognition also plays a role, as familiarity with a company can influence investment decisions.